Angioplasty Balloons Market Overview
The Angioplasty Balloons Market focuses on medical devices used during angioplasty procedures to widen narrowed or blocked blood vessels and restore blood flow. Angioplasty balloons are designed to expand within the affected vessel and help improve circulation, supporting the treatment of coronary and peripheral artery diseases. The market includes drug-eluting balloons, plain old balloons, and scoring balloons used across various cardiovascular interventions.
According to Market Research Future analysis, the Angioplasty Balloons Market was valued at USD 3.38 billion in 2024 and is projected to grow from USD 3.509 billion in 2025 to USD 5.1 billion by 2035, registering a CAGR of 3.81% during the forecast period 2025–2035.
Get Free Sample PDF Brochure:
https://www.marketresearchfuture.com/sample_request/9614
Market Drivers
Rising Prevalence of Cardiovascular Diseases
The increasing prevalence of cardiovascular diseases, including coronary artery disease and peripheral artery disease, is driving demand for angioplasty procedures. As more patients require minimally invasive interventions to restore blood flow, the utilization of angioplasty balloons is expected to increase.
Technological Advancements in Angioplasty Balloons
Technological advancements are contributing significantly to market development. Innovations such as drug-eluting balloons, scoring balloons, improved balloon materials, and advanced delivery systems are helping healthcare providers address complex vascular conditions and improve procedural performance.
Growing Preference for Minimally Invasive Procedures
The growing preference for minimally invasive cardiovascular procedures is supporting demand for angioplasty balloons. Compared with conventional surgical approaches, catheter-based interventions can provide less invasive treatment options for appropriately selected patients, encouraging adoption across hospitals and specialized cardiovascular centers.
Increasing Healthcare Infrastructure Investment
Growing investments in healthcare infrastructure are expanding access to cardiovascular diagnosis and treatment, particularly in emerging markets. The development of advanced hospitals, cardiac catheterization laboratories, and specialized cardiovascular facilities is creating additional opportunities for angioplasty balloon manufacturers.
Increasing Awareness of Cardiovascular Health
Greater awareness of cardiovascular diseases and the importance of early diagnosis and treatment is supporting demand for angioplasty procedures. Public health initiatives and improved access to cardiovascular screening can contribute to earlier identification of vascular conditions requiring intervention.
Market Challenges
Stringent Regulatory Requirements
Angioplasty balloons are medical devices subject to regulatory requirements concerning safety, efficacy, manufacturing quality, and post-market surveillance. Compliance with evolving regulations can increase development timelines and costs for manufacturers.
Risk of Procedural Complications
Angioplasty procedures may involve risks such as vessel injury, restenosis, bleeding, or other cardiovascular complications. These clinical considerations can influence treatment decisions and the adoption of specific angioplasty technologies.
High Cost of Advanced Technologies
Advanced angioplasty balloons, including drug-eluting and specialized scoring balloons, can involve higher costs than conventional balloon technologies. Cost considerations may affect adoption in healthcare systems with limited budgets or reimbursement constraints.
Competition from Alternative Technologies
Angioplasty balloons compete with other cardiovascular intervention technologies, including stents and alternative catheter-based treatment approaches. Product manufacturers therefore need to continuously develop technologies that address clinical and procedural requirements.
Browse In-depth Market Research Report on Angioplasty Balloons Market:
https://www.marketresearchfuture.com/reports/angioplasty-balloons-market-9614
Market Segmentation
By Type:
Drug-Eluting Balloons: Drug-eluting balloons deliver therapeutic medication directly to the treated vessel and represent a significant segment of the market.
Plain Old Balloons: Plain old balloon angioplasty devices are conventional balloon technologies used to dilate narrowed blood vessels during angioplasty procedures.
Scoring Balloons: Scoring balloons incorporate specialized structures designed to assist vessel modification and are increasingly used for selected complex lesions.
By Application:
Coronary Angioplasty: Coronary angioplasty represents a major application, addressing blockages and narrowing in coronary arteries.
Peripheral Angioplasty: Peripheral angioplasty is used to treat narrowed or blocked peripheral arteries and represents an important area of market development.
Renal Angioplasty: Renal angioplasty involves treatment of narrowed renal arteries and represents another application for angioplasty balloon technologies.
By Material:
Polymer: Polymer materials are widely used because of their flexibility, compliance, and suitability for vascular applications.
Latex: Latex represents another material category used in angioplasty balloon manufacturing.
Metal: Metal-based technologies provide strength and durability for selected high-pressure applications.
By End Use:
Hospitals: Hospitals represent a major end-user segment because they provide comprehensive cardiovascular services and specialized catheterization facilities.
Ambulatory Surgical Centers: ASCs are gaining attention as minimally invasive cardiovascular procedures and outpatient treatment models develop.
Cardiac Catheterization Laboratories: Specialized cardiac catheterization laboratories are important settings for angioplasty procedures and the use of balloon catheter technologies.
By Region:
North America: North America represents the largest regional market, supported by advanced healthcare infrastructure, cardiovascular disease prevalence, and adoption of innovative medical technologies.
Europe: Europe benefits from established healthcare systems, medical technology investment, and demand for cardiovascular interventions.
Asia-Pacific: Asia-Pacific is experiencing rapid growth supported by increasing healthcare expenditure, improving infrastructure, and growing awareness of cardiovascular disease.
Middle East & Africa: The Middle East and Africa offer opportunities associated with improving healthcare infrastructure, increasing healthcare investment, and expanding access to cardiovascular treatment.
Regional Insights
North America: North America holds approximately 45% of the global angioplasty balloons market, according to the MRFR report. The United States represents a major market due to advanced healthcare infrastructure, cardiovascular disease burden, and adoption of minimally invasive cardiovascular procedures.
Europe: Europe accounts for approximately 30% of the global market. Countries including Germany, France, and the UK benefit from established healthcare systems, medical technology investment, and demand for advanced cardiovascular procedures.
Asia-Pacific: Asia-Pacific accounts for approximately 20% of the global market and is experiencing rapid development. Increasing healthcare expenditure, improving medical infrastructure, and growing cardiovascular health awareness are supporting regional demand.
Middle East & Africa: The Middle East and Africa account for approximately 5% of the global market. Improving healthcare infrastructure and increasing investments in advanced medical technologies are creating opportunities for market expansion.
Key Players
Boston Scientific
Medtronic
Abbott Laboratories
B. Braun Melsungen AG
Cordis
Terumo Corporation
Asahi Intecc Co., Ltd.
Cook Medical
AngioDynamics
Future Outlook
The Angioplasty Balloons Market is expected to expand through 2035, supported by technological advancements, the increasing prevalence of cardiovascular diseases, rising healthcare expenditure, and continued demand for minimally invasive procedures. The development of drug-eluting balloons, scoring balloons, biodegradable materials, and advanced delivery technologies is expected to create additional opportunities for manufacturers.
The market is projected to reach USD 5.1 billion by 2035, growing at a CAGR of 3.81% from 2025 to 2035.
Explore key developments shaping industry transformation:
Dermatophytic Onychomycosis Treatment Market Forecast
Pharmaceutical Cartridges Market Outlook
Trauma fixation devices Market Analysis
Plasma Therapy Market Distribution
Host Cell Contaminant Testing Market Size
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future provides market research studies covering products, services, technologies, applications, end users, and market players across global, regional, and country-level market segments.
Follow Us: LinkedIn | Twitter
Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
